The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Eli Lilly intensifies its legal efforts against compounding pharmacies producing copycat versions of its weight-loss drugs, ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

Eli Lilly and Novo Nordisk are already the biggest drug companies by market capitalisation that have ever drug companied, and there is reason to think they may be getting even bigger. And the reason, ...

In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company ...

McDonald's is suing major meatpackers for allegedly colluding to inflate beef prices by limiting supplies since 2015. PepsiCo ...

Frantic demand for drugs to treat ... in solid tumours. Weight loss treatments are rapidly becoming a focal point for pharma R&D, driven by the commercial success of Eli Lilly and Novo Nordisk ...

One of the highlights of Eli Lilly's ... weight loss in adults with type 2 diabetes, although the comparison was made before Novo Nordisk launched a higher-strength version of its drug.

Current vice president and Democratic Party presidential nominee Kamala Harris has proposed sweeping changes designed to ...

Take a closer look at 12 biotech unicorns, with a worth of more than $1 billion, that are trying to revolutionize the ...